Amlodipine,valsartan And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 33342-285

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Amlodipine, Valsartan And Hydrochlorothiazide (NDC 33342-285). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

283-30s (283 30s Count)

283-30s (283 30s Count)
This is the packaging information for Amlodipine, Valsartan, and Hydrochlorothiazide tablets, USP. Each film-coated tablet contains Amlodipine Besylate 5 mg, Valsartan 160 mg, and Hydrochlorothiazide 12.5 mg. The usual dosage is specified in the prescribing information. The tablets should be stored at 20°C to 25°C (68°F to 77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F). It is advised to protect the tablets from moisture. Manufactured by Macleods Pharma USA, Inc. Keep out of reach of children.*
FDA Label Image

284-30s (284 30s Count)

284-30s (284 30s Count)
This text appears to be a description of a medication called Amlodipine, Valsartan, and Hydrochlorothiazide tablets, USP. Each film-coated tablet contains Amlodipine Besylate (equivalent to Amlodipine 10 mg), Valsartan 160 mg, and Hydrochlorothiazide 12.5 mg. The usual dosage should be determined based on Prescribing Information. The tablets should be stored between 20°C to 25°C (68°F to 77°F). The manufacturer is Macleods Pharma USA. Remember to keep this medication out of the reach of children.*
FDA Label Image

285-30s (285 30s Count)

285-30s (285 30s Count)
This text is a label for Valsartan and Hydrochlorothiazide tablets. The tablets are film-coated and each tablet contains Amlodipine Besylate equivalent to Amlodipine 5 mg, Valsartan USP 160 mg, and Hydrochlorothiazide USP 25 mg. It mentions the usual dosage instructions and advises to store the tablets at a temperature between 20° to 25°C. The manufacturer is mentioned as Macleods Pharma USA Inc. It also provides recommendations to protect the tablets from moisture and to keep them out of the reach of children.*
FDA Label Image

286-30s (286 30s Count)

286-30s (286 30s Count)
Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP is a medication containing a combination of Amlodipine Besylate, Valsartan, and Hydrochlorothiazide. Each film-coated tablet consists of Amlodipine Besylate equivalent to 10 mg of Amlodipine, Valsartan 160 mg, and Hydrochlorothiazide 25 mg. It is important to follow the usual dosage as directed in the prescribing information for Dosage and Administration. The medication should be stored at room temperature, protected from moisture and kept out of reach of children. Manufactured by Macleods Pharma USA, Inc.*
FDA Label Image

287-100s-carton (287 100s Carton)

287-100s-carton (287 100s Carton)
This description is about Amlodipine, Valsartan, and Hydrochlorothiazide Tablets. It contains important information such as the quantity of tablets, dosage instructions, storage conditions, manufacturer details, and precautions. The tablets are used to treat certain conditions related to blood pressure and heart health. It is essential to keep the medication out of reach of children and follow the prescribed dosage instructions carefully.*
FDA Label Image

287-30s (287 30s Count)

287-30s (287 30s Count)
This text is a description of Amlodipine, Valsartan, and Hydrochlorothiazide tablets. Each film-coated tablet contains Amlodipine 10mg, Valsartan 520mg, and Hydrochlorothiazide 35mg. It mentions the usual dosage and storage instructions to keep the tablets at 20-25°C and out of reach of children. The manufacturer is listed as Madoods Pharms USA, Inc. and the text also includes a Control Room Temperature warning.*
FDA Label Image

287-90s (287 90s Count)

287-90s (287 90s Count)
This text provides information about a medication called Amlodipine, Valsartan, and Hydrochlorothiazide tablets. Each film-coated tablet contains specific amounts of these active ingredients. The text also includes instructions on storage conditions and manufacturer details. It emphasizes keeping the medication out of reach of children. This product is a combination medication typically used to treat high blood pressure.*
FDA Label Image

Amlodipine-struc (Amlodipine)

Amlodipine-struc (Amlodipine)
FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
Not available.*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
This text provides information on Mean Sitting Diastolic Blood Pressure (DBP) measurements in mmHg for different treatment groups over a period of weeks. The treatments mentioned include combinations of medications such as Amlodipine, Valsartan, and Hydrochlorothiazide. It appears to be a chart or table presenting data on blood pressure readings for various treatment groups.*
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
FDA Label Image

Figure-4 (Figure 4)

Figure-4 (Figure 4)
This is a chart showing the Mean Ambulatory Diastolic Blood Pressure (DBP) in millimeters of mercury (mmHg) at different time intervals after dosing with different treatments. The treatments included are Amlodipine/Valsartan/Hydrochlorothiazide (10/320/25 mg), Amlodipine/Valsartan (10/320 mg), Valsartan/Hydrochlorothiazide (320/25 mg), and Hydrochlorothiazide/Amlodipine (25/10 mg).*
FDA Label Image

Figure-5 (Figure 5)

Figure-5 (Figure 5)
FDA Label Image

Hctz-struc (Hydrochlorothiazide)

Hctz-struc (Hydrochlorothiazide)
FDA Label Image

Valsartan-struc (Valsartan)

Valsartan-struc (Valsartan)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.